drugset / Trial / NCT01564706

A Study of 18F-AV-45 in Healthy Volunteers

NCT01564706

Phase 1 Completed 9 enrolled Avid Radiopharmaceuticals
NaSingle-groupOpen-labelDiagnostic

Summary

This study will determine how florbetapir F 18 (18F-AV-45) radioactivity is distributed throughout the body.

Timeline

Start
2007-10
Primary completion
2008-01
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject florbetapir F 18 Diagnostic / imaging agent 370 mbq Intravenous

Indications